All Episodes
Maine SUD Learning Community — 148 episodes
329 | Understanding Eating Disorders in Youth and the Intersection They Have With Substance Use
328 | Updates in HIV PrEP
327 | Guidelines for the Use of Human Milk in the Context of Substance Use Disorder
326 | Creating a Recovery Center in Rural Communities
325 | Peer Recovery Coaching and Reentry | Correctional Legal ECHO: Intersection of Corrections and Healthcare
324 | Methadone Safety and Current Dosing in Opioid Use Disorder
323 | The Modern Illicit Drug Environment, Adulterants, Trends, and Threats
322 | PMP Series | Overdose Reversal Medications
321 | Medication and Treatment for Cannabis Use Disorder
319 | Infectious Disease Syndemic and Substance Use in Maine: From Surveillance to Action
320 | Correctional Legal ECHO: Intersection of Corrections and Healthcare
318 | Alcohol and Cognition: Neurobiology, Neurocognitive Profiles, and Clinical Implications for Assessment and Treatment
317 | Behavioral and Psychological Symptoms of Dementia
316 | Coordinating Initiation and Continuation of Health Services | Correctional Legal ECHO
314 | Psychedelic-Assisted Mental Health Treatment
313 | Psychosis and Substance Use in Adolescents and Young Adults
312 | PMP Series | Considerations for Benzodiazepine Tapering
311 | Management of Fetal Alcohol Spectrum Disorders: Changing the Environment can Change Everything
315 | Arrests and Definitions | Correctional Legal ECHO: Intersection of Corrections and Healthcare
310 | The ABCs of Anxiety and Zzzs: Benzodiazepines and Z-Drugs Explained
309 | Medication Deprescribing
308 | PMP Series: Drivers and Impacts of Drug Diversion among College Students
307 | Exploring the Role of Prescription Stimulants in Treating Stimulant Use Disorder: Rationale, Evidence and Clinical Applications
306 | PMP Series | Buprenorphine Beyond OUD: Chronic Pain and Opioid Stewardship
305 | PMP Series | Stimulant Misuse and Prevention in College Students
304 | The Intersection of Reproductive Health, Contraceptive Care, and Incarceration
303 | Cannabis Hyperemesis Syndrome in Adolescents and Young Adults
302 | Nitrous Oxide Abuse: An Increasingly Common Substance of Abuse
301 | PMP Series | Opioids and Beyond: Safe Strategies for Chronic Pain Treatment
289 | Bridging the Gap: Screening and Accommodations for Patients with TBI in Substance Use Treatment
291 | Driving Fitness, Health, & Aging: Medical-Functional Conditions and Driver Licensing in Maine
290 | Developing Co-Occurring Competency: A Supervisor's Guide
287 | Prenatal Alcohol Exposure, Substance Use Disorder, and Navigating Recovery
286 | Low Barrier Care for Substance Use Treatment
288 | Medications for Older Adults with AUD | Older Adult ECHO: Responsive Care for Aging Adults with SUD
285 | How Do Adulterants Like Quinine, Metamizole, Xylazine, and Medetomidine Impact the Opioid Epidemic?
284 | A Comprehensive Approach to Incarcerated Individuals with Substance Use Disorder: Systems Change at Franklin County Jail
283 | On The Road to Recovery: Maine's Mobile Methadone Unit
282 | Best Practices When Working with Medical Interpreters
281 | Addressing the Impact of Substance Use Stigma in Maine
280 | Cannabis Toolkit: A Resource for Service Providers Working with Youth
279 | Withdrawal Management Case Studies for Nurses
277 | PMP Series | Buprenorphine for Chronic Pain through Positive Childhood Experiences and Positive Psychology
276 | Beyond Awareness: Evidence-Based Strategies for Reducing Stigma in Clinical Practice
278 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | Anxious Aging: Practical Tools for Recognition and Relief
275 | Integrating Care for Complex Needs: FASD, Polysubstance Exposure, and Trauma
274 | The Ripple Effect: Social Impacts on Youth Substance Use | Young Adult ECHO: Treating Adolescent Substance Use
273 | Long term treatment of Alcohol Use Disorder (AUD)
272 | Differentiating "Gas Station Heroin" from Leaf Kratom: Preventing Fourth Wave of Opioid Epidemic
271 | Family Centered Approach | Young Adult ECHO: Treating Adolescent Substance Use
270 | Consent and Confidentiality Issues for Adolescents
269 | Enhancing the Efficacy of Brief Alcohol and Drug Use Interventions for Higher-Risk Emerging Adults
267 | Integrated Skill-based Interventions for People with Co-occurring Conditions, Part 4 of 4
268 | Accessible Wellness: Mindfulness and Relaxation Practices for Your Workday
266 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | "I'm Still Me": Providing individualized care to Older Adults
265 | Young Adult ECHO | Confidentiality: Mental Health versus Substance Use Laws- What's the Difference
264 | Portland Public Health's Overdose Data to Action: LOCAL Community Needs Assessment
265 | Buprenorphine Use in Special Populations
263 | PMP Series | An Opioid Epidemic: The Healthcare Professional's Role in Prevention
262 | Sudden Unexpected Infant Death and Infant Safe Sleep in Maine
261 | Fetal Alcohol Spectrum Disorders: Screening, Diagnosis, and Intervention
258 | Methadone Initiations in the Fentanyl Era: New SAMHSA Rules, New Drug Supply... Same Dosing Protocols?
260 | YA ECHO: Treating Adolescent Substance Use | Reaching Adolescents and Young Adults (AYA) Where They Are
259 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | End of Life Care with SUD
257 | Implementing Rural Community Transportation Services for Behavioral Health Services
256 | CONNECT Outreach Van: Mobile Psychiatry and Substance Use Disorder Treatment for People Experiencing Homelessness
254 | YA ECHO: Treating Adolescent Substance Use | Assessing and Screening: What Works and What Changes are on the Horizon with ASAM
255 | Integrated Stage-Matched Interventions for People with Co-occurring Conditions | part 3 of 4
252 | Integrated Stage-Matched Treatment/Recovery Planning | Part 2 of 4
251 | Integrated Longitudinal Strength-Based Assessment (ILSA) | Part 1 of 4
253 | PMP Series | Understanding the Current Uses and Misuse of Gabapentin
250 | Integration of Traditional Cultural Practices in Behavioral Health Services
249 | YA ECHO: Treating Adolescent Substance Use | Key Development Issues: Risks and Resiliency
248 | Methadone for Opioid Use Disorder for the Generalist: Everything you wanted to know but were afraid to ask
247 | Buprenorphine Formulations
246 | Why Cannabis is NOT the Solution for PTSD
245 | Truth or Hysteria Investigating Cannabis - Fentanyl Contamination
244 | Caring for Affected Others: The Secondary Impact of the Opioid Crisis
243 | Creating Welcoming, Recovery-Oriented, Co-occurring-Capable Services COMPASS-EZ™, Part 2
242 | Understanding your Organizational Baseline using the COMPASS-EZ™, Part 1
241 | Supporting Parents and Guardians with Alcohol Use Disorder: Strategies to Promote Recovery and Family Well-Being
240 | A Discussion about the Special Report by the Maine Accidental Drug Overdose Death Review Panel of Adolescent Cases
239 | PMP Series | Trauma-Informed Deprescribing: How to Align with Patients While Prescribing Responsibly
238 | Low Dose Initiation of Buprenorphine
237 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Culturally Respectful Care for Substance Use Disorders
236 | Applying a Harm Reduction Lens to PrEP Prescribing
235 | Wabanaki Public Health & Wellness: The Road to Creating Substance Use Disorder Programming
234 | Ketamine Therapy for Substance Use Disorders: Theory, Evidence, and Limitations
233 | Addressing the Specific Needs of Women with Substance Use Disorder
232 | Understanding and Reducing Health Stigma
231 | 2-C Drugs and Novel Psychoactive Substances in New England
230 | Adolescent ECHO: Adolescent Medicine: How SUD Fits | Confidentiality for Adolescents
229 | Care for Alcohol Use Disorder Using the Right Tools for the Job
228 | Identifying and Closing Gaps in Care for Mainers with Opioid Use Disorder (OUD)
227 | High Dose Buprenorphine Inductions The Who, What, Where, When, Why, and How
226 | RX ECHO SUD: Through a Pharmacy Lens | Standing Orders
225 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Cultural Responses to Substance Use Services
224 | Critical Updates in Overdose Prevention
223 | The Intersection of Homelessness and Infectious Disease
222 | Adolescent ECHO: Adolescent Medicine | How to Make Your Practice Adolescent and Young Adult Friendly
221 | RX ECHO: SUD Through a Pharmacy Lens | OD Prevention
220 | The Community Care Team Model
219 | Project ECHO: SUD Through a Pharmacy Lens | Harm Reduction
218 | Buprenorphine During Pregnancy and Postpartum
217 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Mi’kmaq Nation Naloxone Vending Machine
216 | Planning for Success: Shared Decision-Making and Outpatient Transition From Fentanyl to Buprenorphine
215 | YA ECHO Adolescent Medicine: How SUD Fits | Navigating the Impact of Addictive Technology on Student Mental Health: A Focus on Social Media and AI
214 | PMP Series | Cannabis Use During Pregnancy Research from Policy to Practice
213 | RX ECHO | SUD Through a Pharmacy Lens: Stigma
212 | Talking with Youth and Families (with MH issues) about Substance Use Podcast
211 | Strategies for Psychopharmacology for Individuals with Co-Occurring Psychiatric and substance use disorders
210 | Older Adults and Substance Use Disorders Trends and Supportive Interventions
209 | Integrating HIV testing into street outreach for unhoused Mainers
208 | Adolescent ECHO: Adolescent Medicine: How SUD Fits | Eating Disorders
207 | PMP Series | Fostering Positive Bonds: Supporting Youth and Families Affected by AUD
206 | Brief introduction to Integrating Peer Support Roles into Multidisciplinary Teams
205 | Welcoming, Integrated Services for People with Co-Occurring Disorders
204 | Contingency Management: An Overview, and our Implementation at MaineHealth
203 | Addressing the Intersection: HIV, Substance Use Disorders, and Evidence-based Approaches to Care
202 | MOUD: Medications for Opioid Use Disorder
201 | The Value of Applying Harm Reduction Principles in Clinical Relationships
127 | HIV & SUD in Maine: How one county's recent HIV cluster highlights important links between SUD & HIV
126 | Evidence-Based Practices in SUD
125 | Methadone and the Oral Cavity
124 | Harm Reduction Efforts in Rural Maine
123 | Welcoming Spaces: Trauma Informed Care for People with SUD
122 | Project ECHO: Methadone in the Age of Fentanyl | Drug Interactions with Methadone
121 | Initiation of Maintenance Medications for Alcohol and Opioid Use Disorders for Nursing
120 | Contingency Management Implementation in Maine
119 | Xylazine: What We Need to Know
118 | Evidence Based Practices for Contingency Management
117 | Polysubstance/Complex Withdrawal Management for Nursing
116 | Quality Improvement Models to Support Implementation, Improvement and Expansion of MOUD and Evidence Based SUD Practices
115 | Project ECHO: Methadone in the Age of Fentanyl | Transitions in Methadone and Buprenorphine
114 | Best and Promising Practices | Interview of Kristen Silvia, MD
113 | Inpatient Treatment of Alcohol Withdrawal Syndrome
112 | Hospital Care of the Opioid Exposed Newborn
111 | Identifying and Supporting People Impacted by Intimate Partner Violence and Substance Use
110 | Best and Promising Practices | SaVida Health OHH Model - Expanding the Boundaries
109 | Best and Promising Practices | Northern Light Inpatient Pharmacy - Advancing MOUD with Whitney Jandreau
108 | Best and Promising Practices | Community Care and Geriatrics: Responding to the needs of patients with OUD/SUD in post-acute and long-term care
107 | Groups Recover Together: How they deliver (and measure) outcome
106 | Best and Promising Practice | St Joseph’s Healthcare XR Buprenorphine Practice: Successes and Challenges
105 | Best and Promising Practice | PenBay Family Medicine Rockport: Making Effective Workflows in Primary Care
104 | Best and Promising Practice | Gilman Clinic: Tips on Treating Hepatitis C in Individuals with SUD/OUD
103 | Best and Promising Practice | Integration of Peers into Medical Practices Treating SUD with Randy Morrison
102 | Promising Practices | Expanding Treatment Programs to Higher Acuity Patients
101 | Best and Promising Practices | York Recovery Center: Creating Rapid Access and Medications First